Dana Marie Roque, MD
MD
Yale University School of Medicine
333 Cedar St.
FMB 328 Box 208063
New Haven,
CT
USA
06520
Biographical Sketch: - Roque DM, et al. Tubulin-?-III overexpression is a marker of poor OS and sn to patupilone in ov clear cell ca. Mol Cancer Res (submitted 6/2012). - Roque DM, et al. Tubulin-?-III overexpression by USC is a marker for poor OS after platinum/taxane chemo"
Papers:
167 - Poster Session A
Weekly ixabepilone with or without concurrent bevacizumab in the treatment of platinum/taxane-resistant endometrial and ovarian cancers: an institutional experience
241 - Poster Session A
Solitomab, an EpCAM/CD3 bispecific antibody (BiTE®), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo